Article Information
History
- November 10, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Andres F. Yepes-Pereza,
- Oscar Herrera-Calderónb,*,
- Lizdany Flórez-Álvarezc,
- María I. Zapata-Cardonac,
- Lina Yepesc,
- Wbeimar Aguilarc,
- María T. Rugelesc and
- Wildeman Zapatac,d
- aChemistry of Colombian Plants, Institute of Chemistry, Faculty of Exact and Natural Sciences, University of Antioquia-UdeA, Calle 70 No. 52-21, A.A 1226, Medellin, Colombia
- bAcademic Department of Pharmacology, Bromatology and Toxicology, Faculty of Pharmacy and Biochemistry, Universidad Nacional Mayor de San Marcos, Jr Puno 1002, Lima 15001, Peru
- cGrupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia UdeA, Medellín, Colombia
- dGrupo Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Medellín, Colombia
- ↵*Corresponding author.
Jr. Puno 1002, Faculty of Pharmacy and Biochemistry, Universidad Nacional Mayor de San Marcos, Lima 15001, Peru. Tel.: + 51 9 56 550 510. E-mail: oherreraca{at}unmsm.edu.pe.
Posted November 10, 2020.
The hydroalcoholic extract of Uncaria tomentosa (Cat’s claw) inhibits the replication of novel coronavirus (SARS-CoV-2) in vitro
